Clinical Trial Update: VLT-015 in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of VLT-015 in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• VLT-015

Snippet

Sponsor: CF Pharma, LLC | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED